Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
1.
Braz. j. infect. dis ; Braz. j. infect. dis;15(2): 163-166, Mar.-Apr. 2011. ilus, tab
Article in English | LILACS | ID: lil-582427

ABSTRACT

OBJECTIVES: Intravenous drug use accounts for most of the new hepatitis C infections worldwide. Although there is an urgent need for antiviral treatment of infected intravenous drug users (IDUs), several factors compromise their treatment including lack of treatment adherence and high dropout rate. The aim of this study was to compare antiviral treatment-related problems among former IDUs to HCV-infected patients without a history of IDU. METHODS: This was a retrospective chart review of HCV-infected IDUs who received combined antiviral therapy at the Hepatology Outpatient Clinic of Szent László Hospital between 1 January 2006 and 31 December 2008. A control group of interferon treated patients with no history of IDU matched for age and sex was selected. RESULTS: Dropout rate was significantly higher in the IDU group (p = 0.016). Treatment response at the 12th week of treatment was significantly better in the IDU group (p = 0.004). Significantly more IDUs underwent antiviral treatment while in prison (p = 0.008). CONCLUSIONS: In this study higher dropout rate was found among IDUs. IDUs had a better response rate to antiviral therapy compared to controls. More attention should be paid to factors that worsen treatment adherence of IDUs - particularly lack of abstinence - in order to increase the effectiveness of antiviral therapy.


Subject(s)
Aged , Humans , Male , Middle Aged , Young Adult , Antiviral Agents/therapeutic use , Hepatitis C, Chronic/drug therapy , Interferons/therapeutic use , Medication Adherence/statistics & numerical data , Substance Abuse, Intravenous/complications , Hepatitis C, Chronic/complications , Retrospective Studies
2.
Arch. Clin. Psychiatry (Impr.) ; Arch. Clin. Psychiatry (Impr.);35(4): 165-169, 2008.
Article in Portuguese | LILACS | ID: lil-492373

ABSTRACT

A terapia convulsiva (TC) constitui uma das principais contribuições européias ao tratamento psiquiátrico moderno e à psiquiatria biológica. A TC foi introduzida na psiquiatria em 1934 por László Meduna, neuropsiquiatra húngaro. As publicações subseqüentes sobre o primeiro paciente tratado com TC, Zoltán L (ZL), baseiam-se nos artigos e na autobiografia de Meduna. De acordo com essas referências, após quatro anos de estupor catatônico, ZL recebeu TC induzida por cânfora que resultou em plena remissão dos sintomas esquizofrênicos, culminando com alta da instituição. Este artigo reconstrói a história do caso de ZL a partir da recente recuperação de anotações - algumas escritas pelo próprio Meduna - dos Arquivos do Instituto Nacional de Psiquiatria e Neurologia (Hungria). Essas anotações mostram que ZL recebeu repetidas sessões de TC entre 1934 e 1937, primeiramente induzidas por cânfora e depois por cardiazol. A primeira série de TC resultou na suspensão do estupor catatônico e na remissão parcial da psicose. Entretanto, a remissão foi breve e, a despeito de repetidas sessões de TC, ZL nunca esteve inteiramente livre de sintomas, nunca teve alta hospitalar e veio a falecer no Instituto em 1945. Na discussão do caso de ZL, tentamos explicar as possíveis razões das discrepâncias entre o relato de Meduna e as notas originais do prontuário médico.


Convulsive therapy (COT) is a major European contribution to the psychiatric armamentarium and biological psychiatry. COT was introduced in psychiatry by László Meduna, a Hungarian neuropsychiatrist. All subsequent publications about the first patient treated with COT, Zoltán L (ZL), were based on Meduna's papers and autobiography. After 4 years of catatonic stupor, ZL received camphor-induced COT which resulted in full remission and discharge from the institution. The aim of this paper is to reconstruct ZL's case history from the original case notes-partly written by Meduna himself-which were recovered from the archives of the National Institute of Psychiatry and Neurology. The case notes show that ZL repeatedly received COT between 1934 and 1937, first with camphor and then with cardiazol induction. After the first course of COT the catatonic stupor was resolved and the psychotic symptoms subsided. However, the remission lasted for only a few months and was followed by a relapse. Despite repeated courses of COT, ZL never became symptom free again, was never discharged and died in the Institute in 1945. This historical case is discussed from both the diagnostic and therapeutic points of view, and an attempt is made to explain the possible reasons for the discrepancies found between Meduna's account and ZL's case notes.


Subject(s)
Humans , Convulsants/therapeutic use , Seizures/therapy , Camphor/therapeutic use , Pentylenetetrazole/therapeutic use , Psychiatry/history
3.
Arch. Clin. Psychiatry (Impr.) ; 28(4): 211-214, 2001.
Article in Portuguese | LILACS | ID: lil-299940

ABSTRACT

Apatia e definida como falta de motivacao nao atribuivel a prejuizo intelectual, estresse emocional ou reducao dos niveis de consciencia. A presenca de apatia, tanto como sintoma quanto como sindrome, e geralmente associada a patologia do lobo frontal ou dos ganglios da base, e...


Subject(s)
Humans , Female , Aged , Brain Stem Infarctions , Depression/diagnosis , Basal Ganglia/pathology , Bromocriptine , Brain Stem Infarctions , Diagnosis, Differential
4.
Arch. Clin. Psychiatry (Impr.) ; 26(3): 56-61, maio-jun. 1999. tab
Article in Portuguese | LILACS | ID: lil-251759

ABSTRACT

A bush-Francis Catatonia Rating Scale (BFCRS) e o primeiro instrumento valido desenvolvido exclusivamente para a avaliacao da sindrome catatonica. Neste estudo, os autores investigaram a hipotese de que a BFCRS pode ser valida e confiavel para a avaliacao transversal de condicoes catatonicas agudas e cronicas, mas ela pode ser inferior a observacao clinica longitudinal para fornecer informacao sobre a severidade de fenomenos catatonicos em pacientes com esquizofrenia cronica...


Subject(s)
Humans , Male , Female , Catatonia/therapy , Antipsychotic Agents/therapeutic use , Schizophrenia, Catatonic/therapy , Follow-Up Studies , Psychiatric Status Rating Scales
SELECTION OF CITATIONS
SEARCH DETAIL